Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 1 |
2025 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases.
J Crohns Colitis. 2022 Jul 14;16(6):1010. doi: 10.1093/ecco-jcc/jjab107.
J Crohns Colitis. 2022.
PMID: 34850867
No abstract available.
Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases.
Coletta M, Paroni M, Alvisi MF, De Luca M, Rulli E, Mazza S, Facciotti F, Lattanzi G, Strati F, Abrignani S, Fantini MC, Vecchi M, Geginat J, Caprioli F.
Coletta M, et al.
J Crohns Colitis. 2020 Sep 16;14(9):1190-1201. doi: 10.1093/ecco-jcc/jjaa035.
J Crohns Colitis. 2020.
PMID: 32100016
Clinical Trial.
BACKGROUND AND AIMS: Vedolizumab [VDZ] is a monoclonal antibody directed against the alpha4beta7 integrin heterodimer, approved for patients with inflammatory bowel diseases [IBD]. This study aimed at identifying immunological variable …
BACKGROUND AND AIMS: Vedolizumab [VDZ] is a monoclonal antibody directed against the alpha4beta7 integrin heterodimer, approved for …
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.